Cellino

Cellino's mission is to enable patients to access personalized autologous cell therapies. Stem cell-derived regenerative medicines hold the promise of curing some of the most challenging diseases, including Parkinson’s disease, diabetes, and heart disease, within this decade. Patient-specific cells offer the safest and most effective treatment for these conditions. However, due to extensive manual handling, high variability, and costly facility overheads, current autologous processes cannot scale. Cellino’s vision is to make personalized regenerative medicine scalable for the first time.